|
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).
Muller And Phipps (Ceylon) Plc
Main Activities: Pharmaceutical and Medicine Manufacturing
 |
Please check the full coverage of information what EMIS can offer you. | SEE SAMPLE |
Company Information |
|
Full name Muller And Phipps Ceylon Plc (Muller And Phipps Ceylon Plc) Headquarters 27-3/1, Leyden Bastian Road, York Arcade Building; Colombo; Western Province; 00100 |
Status: Listed Legal Form: Public Limited Company Operational Status: Operational ISIN CODE : LK0126N00009 Financial Auditors: KPMG (2011) Tel: 011 - 2431214,011 - 2438591 |
|
Company Description |
|
Muller & Phipps (Ceylon) PLC, through its subsidiaries, operates as a service agent representative in Sri Lanka for foreign pharmaceutical companies. It engages in the import, wholesale, and distribution of pharmaceutical products in Sri Lanka. The company was incorporated in 1964 and is based in Colombo, Sri Lanka. Muller &Phipps (Ceylon) PLC is a subsidiary of E. B. Creasy & Company PLC. |
Company Analysis |
| According to the Consolidated - Non-Audited financial statement for the first three cumulated quarters of 2012, total net operating revenues increased with 16.41%, from LKR 279,700 thousands to LKR 325,596 thousands. Operating result increased from LKR 26,048 thousands to LKR 32,358 thousands which means 24.22% change. The results of the period increased 34.81% reaching LKR 24,540 thousands at the end of the period against LKR 18,203 thousands last year. Return on equity (Net income/Total equity) went from 18.05% to 18.72%, the Return On Asset (Net income / Total Asset) went from 9.63% to 9.50% and the Net Profit Margin (Net Income/Net Sales) went from 6.51% to 7.54% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 97.07% compared to 87.35% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 2.19 to 2.00 when compared to the previous year. |
Key Executives |
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
Companies with Similar Main Activities |
FULL COMPANY PROFILE
|
|
2012 Q3C (cons) |
2012 Q2C (cons) |
|
 | ||
| Non-Audited | Non-Audited | |
| ||
| WVB Company Financials | WVB Company Financials | |
| ||
| Unit | Thousands | Thousands |
| ||
Balance Sheet
| ||
Total Assets |
258,306 |
223,605 |
| ||
Current Assets |
239,666 |
204,678 |
| ||
Total Liabilities |
127,233 |
99,723 |
| ||
Shareholders Equity |
131,073 |
123,882 |
| ||
Current Liabilities |
120,000 |
92,775 |
| ||
| * All the accounts are in LKR. | ||
Income Statement
| ||
Total Operating Revenue |
325,596 |
226,656 |
| ||
Operational Profit (Loss) |
32,358 |
22,635 |
| ||
Net Profit (Loss) |
24,540 |
17,349 |
| ||
| * All the accounts are in LKR. | ||
Ratios
| Profitability Ratios | ||
| ||
Return on Assets (ROA) |
9.5% |
7.76% |
| ||
Annualised Return on Assets (ROA) |
12.67% |
15.52% |
| ||
Return on Equity (ROE) |
18.72% |
14% |
| ||
Annualised Return on Equity (ROE) |
24.96% |
28% |
| ||
Return on Sales (ROS) |
7.61% |
7.69% |
| ||
Return on Capital |
18.72% |
14% |
| ||
Gross Profit Margin |
23.29% |
23.05% |
| ||
Operating Profit Margin |
9.37% |
9.79% |
| Efficiency Ratios | ||
| ||
Accounts Receivable Turnover |
3.53x |
2.54x |
| ||
Inventory Turnover |
1.90x |
1.70x |
| ||
Current asset turnover |
1.35x |
1.10x |
| ||
Fixed-asset turnover |
17.30x |
11.91x |
| ||
Asset Turnover |
1.25x |
1.01x |
| Valuation figures and ratios | ||
| ||
Earning Before Interests and Taxes (EBIT) |
32,358 |
22,635 |
| ||
EBITDA |
33,276 |
23,247 |
| ||
Enterprise value |
791,861 |
931,097 |
| ||
Enterprise Value / EBITDA |
23.80 |
40.05 |
| ||
Bookvalue (BV) |
252,893 |
195,506 |
| ||
Net Cash |
-114,048 |
-90,173 |
| Liquidity Ratios | ||
| ||
Current Ratio |
199.72% |
220.62% |
| ||
Quick ratio |
91.38% |
110.53% |
| ||
Doom's day ratio |
4.96% |
2.8% |
| Leverage Ratios | ||
| ||
Leverage ratio |
197.07% |
180.5% |
| ||
Debt to equity |
97.07% |
80.5% |
| ||
Debt to total assets |
49.26% |
44.6% |
| ||
Long Term Debt to Capital |
8.02% |
7.72% |
| ||
Debt / Enterprise Value |
0.68% |
3.02% |
| Market ratios | ||
| ||
Market Capitalization/EBITDA |
23.81 |
38.96 |
| ||
Price/Book Ratio |
3.13 |
4.63 |
| ||
Market Cap / Net cash |
-6.95 |
-10.04 |
| Trend Ratios | ||
| ||
Revenue Trend |
116.86% |
119.74% |
| ||
Net Income Trend |
134.81% |
112.88% |
| ||
Operating Income Trend |
124.22% |
113.84% |
| ||
 |